Close Menu
  • Home
  • Stock
  • Parenting
  • Personal
  • Fashion & Beauty
  • Finance & Business
  • Marketing
  • Health & Fitness
  • Tech & Gadgets
  • Travel & Adventure

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

What's Hot

Supergiant Star Wd1-9 Investigated: Know Everything about New Findings and Insights from Supergiant Star

agosto 3, 2025

Massive 200-Light-Year Cloud May Be Channeling Matter to the Milky Way’s Core

agosto 3, 2025

New Inelastic Dark Matter Model Could Bypass Current Limits of Particle Detection

agosto 3, 2025
Facebook X (Twitter) Instagram
  • Home
  • Contact us
  • DMCA
  • Política de Privacidad
  • Publicidad en DD Noticias
  • Sobre Nosotros
  • Términos y Condiciones
Facebook X (Twitter) Instagram
DD Noticias: Tu fuente de inspiración diariaDD Noticias: Tu fuente de inspiración diaria
  • Home
  • Stock
  • Parenting
  • Personal
  • Fashion & Beauty
  • Finance & Business
  • Marketing
  • Health & Fitness
  • Tech & Gadgets
  • Travel & Adventure
DD Noticias: Tu fuente de inspiración diariaDD Noticias: Tu fuente de inspiración diaria
Home » Elon Musk’s Neuralink to Test Brain Chips in Clinical Study in Great Britain
Technology & Gadgets

Elon Musk’s Neuralink to Test Brain Chips in Clinical Study in Great Britain

Jane AustenBy Jane Austenagosto 2, 2025No hay comentarios1 Min Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email


Elon Musk’s brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its chips can enable patients with severe paralysis to control digital and physical tools with their thoughts.

The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study, it said in a post on X.

Neuralink said patients living with paralysis due to conditions such as spinal cord injury and a nervous system disease called Amyotrophic Lateral Sclerosis (ALS) qualify to participate in the study.

The company raised $650 million (roughly Rs. 5,676 crore) in its latest funding round last month. It began human trials in 2024 on its brain implant after resolving safety concerns flagged by the US Food and Drug Administration, which had initially rejected Neuralink’s application in 2022.

According to the company, five patients with severe paralysis are currently using its device to control digital and physical tools with their thoughts.

Neuralink, founded in 2016, has raised about $1.3 billion (roughly Rs. 11,360 crore) from investors and is valued at roughly $9 billion (roughly Rs. 78,714 crore), according to media reports, citing PitchBook.

© Thomson Reuters 2025



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Jane Austen
  • Website

Related Posts

Supergiant Star Wd1-9 Investigated: Know Everything about New Findings and Insights from Supergiant Star

agosto 3, 2025

Massive 200-Light-Year Cloud May Be Channeling Matter to the Milky Way’s Core

agosto 3, 2025

New Inelastic Dark Matter Model Could Bypass Current Limits of Particle Detection

agosto 3, 2025
Add A Comment
Leave A Reply Cancel Reply

Editors Picks

Fast fashion pioneer Forever 21 files for bankruptcy — again

marzo 18, 2025

Dow gains 350 points as stocks climb for 2nd day after S&P 500 enters correction

marzo 18, 2025

Yellow Creditors Have Own Plan to Share Trucker’s $550 Million

marzo 18, 2025

Alphabet in Talks to Buy Startup Wiz for $30 Billion, WSJ Says

marzo 18, 2025
Top Reviews
DD Noticias: Tu fuente de inspiración diaria
Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
  • Home
  • Contact us
  • DMCA
  • Política de Privacidad
  • Publicidad en DD Noticias
  • Sobre Nosotros
  • Términos y Condiciones
© 2025 ddnoticias. Designed by ddnoticias.

Type above and press Enter to search. Press Esc to cancel.